FDA clears first ACL reconstruction device for use in paediatric patients
January 11, 2023Medical Communications
The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant …
AbbVie and Anima collaborate for mRNA biology modulators
January 11, 2023Research and Development
AbbVie and Amina Biotech have announced their collaboration for the discovery and development of mRNA biology modulators focusing on three …
FDA grants approval to third-generation VERO Biotech GENOSYL delivery system
January 11, 2023Research and Development
The FDA has approved US-based medical equipment supplier VERO Biotech’s new-generation tankless inhaled nitric oxide (iNO) delivery system. This new …
BioNTech acquires AI company InstaDeep for £562m
January 11, 2023Medical Communications
Germany-based BioNTech has acquired UK AI start up InstaDeep for £562m after a multi-year partnership. The acquisition is part of …
Insilico Medicine shares positive topline results of phase 1 trial of AI-designed drug for AI-discovered target
January 10, 2023Medical Communications
Clinical stage AI-driven drug R&D company, Insilico Medicine, has announced positive topline results from its phase 1 trial assessing the …
FDA issues Emergency Use Authorisation for BD and CerTest Biotec’s Monkeypox PCR test
January 10, 2023Medical Communications
US medical technology company BD and Spanish biotechnology company CerTest Biotec have joined forces to develop a real-time Monkeypox test …
Day One Biopharmaceuticals to file NDA for paediatric brain cancer treatment before second half of 2023
January 10, 2023Research and Development
Day One Biopharmaceuticals is set to ask the FDA for approval for tovorafenib before the summer of 2023. Tovorafenib is …
NHS to offer artificial pancreas to type 1 diabetes patients
January 10, 2023Medical Communications
The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England …
STORM Therapeutics Expands R&D Leadership Team
January 10, 2023Business Services
10 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …
Positive Initial Data Analysis in POLB 001 LPS Challenge Trial
January 9, 2023Business Services
9 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …
Novo Holdings invests in proteomics technology company, Evosep
January 9, 2023Business Services
The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep’s …
FDA approves Eisai-Biogen’s lecanemab for Alzheimer’s disease
January 9, 2023Research and Development
The FDA has approved Eisai and Biogen’s experimental antibody treatment lecanemab (also known as Leqembi) for the treatment of mild …
AstraZeneca set to buy CinCor for $1.8bn
January 9, 2023Sales and Marketing
AstraZeneca has announced that it is set to acquire the clinical-stage biopharmaceutical company CinCor in a deal worth up to …
$22m raised by PBS Biotech to expand single-use manufacturing products and services for cell therapy clients
January 9, 2023Manufacturing and Production
PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider, has worked together with Avego Management and BroadOak …
Sarepta Therapeutics and Catalent sign manufacturing deal for DMD gene therapy approval
January 9, 2023Manufacturing and Production
Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. …
James Noble
January 6, 2023Business Services
St Andrews, UK – 6 January 2023 – Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal …
Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration
January 6, 2023Business Services
Strasbourg, France, January 6, 2023, 7:30 a.m.
Sanofi plans eco-friendly additions to Brisbane manufacturing campus
January 6, 2023Manufacturing and Production
Sanofi is aiming to expand its eco-friendly and renewable energy ecosystem with plans to install solar panels on the carpark, …
Moderna agrees first acquisition for $85m
January 6, 2023Sales and Marketing
After a pivotal few years, Moderna has agreed its first acquisition, worth $85m, which will allow the company access to …
BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies
January 6, 2023Medical Communications
German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
